机构:[1]Institute of Traditional Chinese Medicine & Natural Products, Jinan University, Guangzhou 510632, China[2]State Key Laboratory of Oral Diseases, West China Hospital of Stomatology, Sichuan University, Chengdu 610041, China.[3]State Key Laboratory of Biotherapy & Collaborative Innovation Center of Biotherapy, West China Hospital, Sichuan University, Chengdu 610041, China.四川大学华西医院
Family with sequence similarity 20, member C (Fam20C) is a physiological Golgi casein kinase that phosphorylates multiple secreted proteins. Recently, it has been reported that Fam20C can be identified as a novel kinase target for therapeutic development. Thus, inhibition of Fam20C will be a potential therapeutic strategy to prevent tumor cell progression and metastasis. In our study, based upon the systems-biology network, molecular modeling and molecular dynamics (MD) simulations, we discovered a novel Fam20C inhibitor (FL-1607) with potent anti-proliferative effects on triple-negative breast cancer (TNBC) cells. Subsequently, we found that this Fam20C inhibitor could induce apoptosis and inhibit cell migration in MDA-MB-468 cells. Together, these findings would provide a new clue to the exploration of more novel Fam20C inhibitors for future TNBC therapy.
基金:
Postdoctoral
Science Foundation (2015M580794).
语种:
外文
PubmedID:
中科院(CAS)分区:
出版当年[2016]版:
大类|3 区生物
小类|3 区生化与分子生物学
最新[2025]版:
无
第一作者:
第一作者机构:[1]Institute of Traditional Chinese Medicine & Natural Products, Jinan University, Guangzhou 510632, China
共同第一作者:
通讯作者:
推荐引用方式(GB/T 7714):
Qin Ziyi,Wang Peiqi,Li Xinyi,et al.Systematic network-based discovery of a Fam20C inhibitor (FL-1607) with apoptosis modulation in triple-negative breast cancer.[J].Molecular bioSystems.2016,12(7):2108-18.doi:10.1039/c6mb00111d.
APA:
Qin Ziyi,Wang Peiqi,Li Xinyi,Zhang Shouyue,Tian Mao...&Fu Leilei.(2016).Systematic network-based discovery of a Fam20C inhibitor (FL-1607) with apoptosis modulation in triple-negative breast cancer..Molecular bioSystems,12,(7)
MLA:
Qin Ziyi,et al."Systematic network-based discovery of a Fam20C inhibitor (FL-1607) with apoptosis modulation in triple-negative breast cancer.".Molecular bioSystems 12..7(2016):2108-18